As of 2025-11-17, the Relative Valuation of Bright Minds Biosciences Inc (DRUG.CN) is - CAD. This relative valuation is based on P/E multiples. With the latest stock price at 81.29 CAD, the upside of Bright Minds Biosciences Inc based on Relative Valuation is -.
The range of the Relative Valuation is - CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | P/E |
| 2025-11-11 | -70.97 |
| 2025-11-10 | -72.69 |
| 2025-11-04 | -63.61 |
| 2025-10-31 | -67.33 |
| 2025-10-30 | -64.49 |
| 2025-10-29 | -67.90 |
| 2025-10-28 | -71.22 |
| 2025-10-27 | -71.23 |
| 2025-10-24 | -75.51 |
| 2025-10-23 | -74.91 |
| 2025-10-22 | -74.12 |
| 2025-10-21 | -82.55 |
| 2025-10-20 | -81.20 |
| 2025-10-16 | -84.30 |
| 2025-10-15 | -79.40 |
| 2025-10-14 | -83.61 |
| 2025-10-10 | -76.00 |
| 2025-10-09 | -75.07 |
| 2025-10-07 | -61.25 |
| 2025-10-06 | -62.04 |
| 2025-10-03 | -66.43 |
| 2025-10-01 | -70.72 |
| 2025-09-30 | -73.72 |
| 2025-09-29 | -71.63 |
| 2025-09-26 | -65.42 |
| 2025-09-24 | -61.72 |
| 2025-09-22 | -60.72 |
| 2025-09-19 | -62.92 |
| 2025-09-18 | -60.54 |
| 2025-09-16 | -59.14 |
| 2025-09-11 | -54.00 |
| 2025-09-09 | -50.72 |
| 2025-09-08 | -50.41 |
| 2025-09-05 | -53.29 |
| 2025-09-04 | -55.29 |
| 2025-09-02 | -47.17 |
| 2025-08-28 | -51.20 |
| 2025-08-27 | -52.85 |
| 2025-08-26 | -50.62 |
| 2025-08-19 | -51.16 |
| 2025-08-18 | -52.43 |